Imidazopyridazines as Akt kinase inhibitors

US9206185B2 · kind B2 · utility

Assignee

• Bayer Intellectual Property GmbH · DE

Inventors

• Lars Bärfacker · Oberhausen, DE
• William Scott · Guilford, US
• Andrea Hägebarth · Berlin, DE
• Stuart Ince · Berlin, DE
• Hartmut Rehwinkel · Berlin, DE
• Oliver Politz · Panketal, DE
• Roland Neuhaus · Berlin, DE
• Hans Briem · Bremen, DE
• Ulf Bömer · Glienicke, DE

Key dates

• Filing date: Apr 5, 2012
• Grant date: Dec 8, 2015
• Expiry date: Apr 5, 2032

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61P43/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The application relates to imidazopyridazines of formula (I)which are useful as Akt inhibitors suitable for the treatment of cancer, and processes for their production and the use thereof.